Although the literature is conflicting regarding the level of PKCα expression in breast cancers compared to the normal breast[32-36], variability in PKCα expression amongst breast cancers and the link to endocrine resistance and tumor aggressiveness is clear. The gene discussed is PRKCA; the disease is neoplasm.